Madhi SA - Search Results

1

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.

Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Madhi SA, et al. Vaccine. 2013 Aug 28;31 Suppl 4:D52-7. doi: 10.1016/j.vaccine.2013.02.029. Vaccine. 2013. PMID: 23973347 Review.

2

High burden of invasive Streptococcus agalactiae disease in South African infants.

Madhi SA, Radebe K, Crewe-Brown H, Frasch CE, Arakere G, Mokhachane M, Kimura A. Madhi SA, et al. Ann Trop Paediatr. 2003 Mar;23(1):15-23. doi: 10.1179/000349803125002814. Ann Trop Paediatr. 2003. PMID: 12648320

3

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. Klugman KP, et al. Among authors: madhi sa. N Engl J Med. 2003 Oct 2;349(14):1341-8. doi: 10.1056/NEJMoa035060. N Engl J Med. 2003. PMID: 14523142 Free article. Clinical Trial.

4

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.

Madhi SA, Kuwanda L, Cutland C, Klugman KP. Madhi SA, et al. Clin Infect Dis. 2005 May 15;40(10):1511-8. doi: 10.1086/429828. Epub 2005 Apr 7. Clin Infect Dis. 2005. PMID: 15844075 Clinical Trial.

5

Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.

Madhi SA, Kuwanda L, Saarinen L, Cutland C, Mothupi R, Käyhty H, Klugman KP. Madhi SA, et al. Vaccine. 2005 Dec 1;23(48-49):5517-25. doi: 10.1016/j.vaccine.2005.07.038. Epub 2005 Aug 1. Vaccine. 2005. PMID: 16107294

6

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers.

Madhi SA, Cutland C, Zhu Y, Hackell JG, Newman F, Blackburn N, Murphy BR, Belshe RB, Karron RA, Deatly AM, Gruber WC, Bernstein DI, Wright PF. Madhi SA, et al. Vaccine. 2006 Mar 20;24(13):2432-9. doi: 10.1016/j.vaccine.2005.12.002. Epub 2005 Dec 20. Vaccine. 2006. PMID: 16406170 Clinical Trial.

7

World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines.

Madhi SA, Klugman KP. Madhi SA, et al. Vaccine. 2007 Mar 22;25(13):2413-9. doi: 10.1016/j.vaccine.2006.09.010. Epub 2006 Sep 18. Vaccine. 2007. PMID: 17005301

8

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.

Madhi SA, Adrian P, Kuwanda L, Jassat W, Jones S, Little T, Soininen A, Cutland C, Klugman KP. Madhi SA, et al. Vaccine. 2007 Mar 22;25(13):2451-7. doi: 10.1016/j.vaccine.2006.09.019. Epub 2006 Sep 20. Vaccine. 2007. PMID: 17023095 Clinical Trial.

9

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R. Siber GR, et al. Among authors: madhi sa. Vaccine. 2007 May 10;25(19):3816-26. doi: 10.1016/j.vaccine.2007.01.119. Epub 2007 Feb 21. Vaccine. 2007. PMID: 17368878

10

Lessons learned from clinical trials evaluating pneumococcal conjugate vaccine efficacy against pneumonia and invasive disease.

Madhi SA, Whitney CG, Nohynek H. Madhi SA, et al. Vaccine. 2008 Jun 16;26 Suppl 2:B9-B15. doi: 10.1016/j.vaccine.2008.06.001. Vaccine. 2008. PMID: 18793605 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

701 results

Search Page

Filters